Ipca Laboratories Ltd Share Price (IPCALAB)
as on
| Source : NSE
Ipca Laboratories Ltd Stock Performance
as on August 14, 2025 at 4:01 PM IST
Day's Low
Day's High
₹1,350.5₹1,403
1.13%
Downside
2.72%
Upside
52 Week's Low
52 Week's High
₹1,168.2₹1,755.914.47%
Downside
28.55%
Upside
| Market Stats | |
| Previous Close | ₹1,364.60 |
| Open | ₹1,376.00 |
| Volume | 95.38K |
| Upper Circuit | ₹1,637.50 |
| Lower Circuit | ₹1,091.70 |
| Day's Low | ₹1,350.5 |
| Day's High | ₹1,403 |
| 52 Week Low | ₹1,168.2 |
| 52 Week High | ₹1,755.9 |
| Returns % | |
| 1 Month Return | -6.56 % |
| 3 Month Return | -1.92 % |
| 1 Year Return | + 2.09 % |
| 3 Year Return | + 47.51 % |
| 5 Year Return | + 36.48 % |
Ipca Laboratories Ltd Stock Fundamentals & Key Indicators
Check Ipca Laboratories Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹34,653.46 Cr
Return on Equity (ROE)
12.39
PE Ratio (TTM)
44.51
Return on capital employed (ROCE)
17.21
Industry PE ratio
43.28
Beta (LTM)
0.84
P/B Ratio
5.53
Dividend Yield
0.27
PEG Ratio
5.6
Quarterly Earnings Growth YOY
17.81
EPS (TTM)
31.04
Sector
Pharmaceuticals
Book Value
273.88
Technical Analysis
Bearish
View Technical Analysis
Ipca Laboratories Ltd Stock's Interest Amongst Investors
Ipca Laboratories Ltd Stock Valuation
Track how Ipca Laboratories Ltd P/E has moved over time to understand its valuation trends.
Ipca Laboratories Ltd in the last 5 years
Lowest (18.72x)
October 10, 2019
Industry (43.28x)
August 14, 2025
Today (44.51x)
August 14, 2025
Highest (65.89x)
September 25, 2024
Today’s Price to Earnings Ratio: 44.51x
Ipca Laboratories Ltd Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Ipca Laboratories Ltd.
based on 17 analysts
58.82%
Buy
17.65%
Hold
23.53%
Sell
58.82% of analysts recommend a 'BUY' rating for Ipca Laboratories Ltd. Average target price of ₹1495.65
Source: S&P Global Market Intelligence
Ipca Laboratories Ltd Share Price Target
Get share price movements and forecasts by analysts on Ipca Laboratories Ltd.
Ipca Laboratories Ltd price forecast by 17 analysts
Upside of9.50%
High
₹1810
Target
₹1495.65
Low
₹1106
Ipca Laboratories Ltd target price ₹1495.65, a slight upside of 9.5% compared to current price of ₹1365.9. According to 17 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Ipca Laboratories Ltd revenue growth forecast
Expected growth rate Q1, FY2027:23.71%
Forecast
Actual
Including amortisation and stock based compensations
Ipca Laboratories Ltd EPS growth forecast
EPS estimate Q1, FY2027:86.11%
Forecast
Actual
Source: S&P Global Market Intelligence
Ipca Laboratories Ltd Financial Results
Get the annual and quarterly financial summary of Ipca Laboratories Ltd, including revenue, profit, loss and more.
Ipca Laboratories Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Ipca Laboratories Ltd.
Ipca Laboratories Ltd Earnings Results
Ipca Laboratories Ltd’s net profit jumped 21.31% since last year same period to ₹233.21Cr in the Q1 2025-2026. On a quarterly growth basis, Ipca Laboratories Ltd has generated 243.87% jump in its net profits since last 3-months.
Read More about Earnings ResultsIpca Laboratories Ltd Dividends May,2025
In the quarter ending March 2025, Ipca Laboratories Ltd has declared dividend of ₹2.00 per share on 29 May 2025 - translating a dividend yield of 0.44%.
Read More about Dividends
Indices Featuring Ipca Laboratories Ltd Stock
Check stock indices that include Ipca Laboratories Ltd.
Ipca Laboratories Ltd Stock Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Ipca Laboratories Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 44.72% | 0.00 | |
| Foreign Institutions | 10.67% | ||
| Mutual Funds | 29.61% | ||
| Retail Investors | 8.41% | ||
| Others | 6.59% | 2.53 |
Ipca Laboratories Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Ipca Laboratories Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 34,653.46 | 7.3% | 0.65 | 787 | 8,939 | |
| BUY | 11,690.03 | -7.88% | 0.52 | 413 | 2,013 | |
| BUY | 63,492.31 | 5.11% | 0.59 | 3,483 | 31,723 | |
| HOLD | 99,496.42 | 29.75% | 0.61 | 4,614 | 23,241 | |
| BUY | 70,688.13 | 19.9% | 0.00 | 1,414 | 6,445 |
Ipca Laboratories Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Ipca Laboratories Ltd.
Ipca Laboratories Reports Weaker Q1 Performance - 12 Aug, 2025
Ipca Laboratories' Q1 performance fell short of expectations, primarily due to low margins at Unichem Laboratories and weak domestic growth. Despite a 21% rise in consolidated profit and a 10% increase in revenue year-on-year, the stock rose 1.4%, reducing year-to-date losses to approximately 20%.Ipca Laboratories Reports Strong Q1 Earnings Growth - 11 Aug, 2025
Ipca Laboratories announced a 21.31% increase in net profit to Rs 233.21 crore for Q1 FY26, driven by a 10.33% rise in sales. Despite positive results, shares fell by approximately 3.62%.Ipca Laboratories Shows Bullish Momentum and Buy Recommendations - 31 Jul, 2025
Ipca Laboratories is experiencing a bullish breakout with strong technical indicators. Analysts recommend buying at current prices or dips, targeting ₹1,650-1,740, with a stop loss at ₹1,475.
Insights on Ipca Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, 67.82 Cr → 233.21 Cr (in ₹), with an average increase of 70.9% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 2.26K Cr → 2.34K Cr (in ₹), with an average increase of 1.6% per quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, IPCALAB stock has moved up by 2.2%
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 32.3% return, outperforming this stock by 30.2%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 44.72% of holdings in Jun 2025 quarter
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 130.2% return, outperforming this stock by 82.7%
NEGATIVE IMPACTMF Holding Down
Mutual Funds have decreased holdings from 29.63% to 29.61% in Jun 2025 quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 10.76% to 10.67% in Jun 2025 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 8.46% to 8.41% in Jun 2025 quarter
About Ipca Laboratories Ltd
Revenue: ₹2,308.85Cr as on June 2025 (Q1 FY26)
Net Profit: ₹234.42Cr as on June 2025 (Q1 FY26)
Listing date: 03 Nov, 1994
Chairperson Name: Premchand Godha
| Organisation | Ipca Laboratories Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| CEO | Premchand Godha |
| E-voting on shares | Click here to vote |
Mutual Funds that own Ipca Laboratories Ltd Stock
Check out the Mutual Funds with significant holdings in Ipca Laboratories Ltd.
FAQs
What is Ipca Laboratories Ltd share price today?
Ipca Laboratories Ltd share price today stands at ₹1365.9, Open: ₹1376, Previous Close: ₹1364.6, High: ₹1403, Low: ₹1350.5, 52 Week High: ₹1755.9, 52 Week Low: ₹1168.2 as on .
How to buy Ipca Laboratories Ltd shares ?
To buy Ipca Laboratories Ltd shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for IPCALAB or Ipca Laboratories Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Ipca Laboratories Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is today's traded volume of Ipca Laboratories Ltd?
Today's traded volume of Ipca Laboratories Ltd is 95.38K. Which means that 95.38K shares of Ipca Laboratories Ltd were bought and sold on the stock market during today's trading session.
What is Ipca Laboratories Ltd's market cap today?
Today's market capitalisation of Ipca Laboratories Ltd is ₹34,653.46 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Ipca Laboratories Ltd?
Ipca Laboratories Ltd’s 52 week high is ₹1755.9 and 52 week low is ₹1168.2. The current share price of Ipca Laboratories Ltd is ₹1365.9, which is -22.21% down from its 52 week high and 16.92% up from its 52 week low.